Judge slashes Lilly, Takeda's $9bn Actos punitive award
This article was originally published in Scrip
Executive Summary
A US judge has drastically reduced the $9bn combined punitive damage payment awarded against Lilly and Takeda over their antidiabetic Actos (pioglitazone). However, their bid to have a retrial was rejected by District Judge Rebecca Doherty in Louisiana.